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Abstract
Chelated ruthenium catalysts have achieved highly chemoselective olefin metathesis reactions.
Terminal and internal Z olefins were selectively reacted in the presence of internal E olefins.
Products were produced in good yield and high stereoselectivity for formation of a new Z olefin.
No products of metathesis with the internal E olefin were observed. Chemoselectivity for terminal
olefins was also observed over both sterically hindered and electronically deactivated alkenes.
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Olefin metathesis catalyzed by transition metal carbene complexes has developed as an
important technique in the manipulation of carbon-carbon double bonds. [1] The
development and subsequent commercial availability of highly active catalyst complexes
has allowed olefin metathesis to have an important synthetic impact on fields ranging from
materials science,[2] to biochemistry,[3] to natural products synthesis. [4]
Chemoselectivity, in general, is a current and outstanding problem in organic synthesis.[5]
The synthetic utility of olefin metathesis is underscored by the orthogonal reactivity of
carbon-carbon double bonds to many organic functional groups. However, in contrast to
ring-closing metathesis, cross metathesis has received relatively fewer synthetic applications
because of the low stereo- and chemoselectivity observed when previous generations of
metathesis catalysts such as 1 and 2 are used.[6] Selective olefin metathesis methods would
be useful for the construction of new carbon-carbon double bonds; however, chemoselective
cross metathesis reactions of dienes are rare. [7,8] Until recently, metathesis of dienes where
one olefin was inert to reaction was limited to olefins differentiated by either electronic or
steric properties,[9] with some limited examples in macrocyclic ring-closing metathesis.[10]
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Recent advances in catalyst development have produced new metathesis catalysts that are
highly Z-selective (3–6, Figure 1). The Schrock and Hoveyda groups initially reported
molybdenum and tungsten monoaryloxide pyrrolide (MAP) catalysts (e.g. 3 and 4) that have
now been shown to conduct Z-selective dimerization and cross metathesis of terminal
olefins[11], ring-opening metathesis polymerization,[12] as well as macrocyclic ring-closing
metathesis[13] with high levels of Z-selectivity. Our group then reported chelated catalysts 5
and 6 as the most effective ruthenium catalysts for Z-selective olefin metathesis of terminal
and internal Z-olefins, with turnover numbers as high as 7400 and Z-selectivity of >95% in
many cases. [14] The synthetic promise of these ruthenium complexes has been presented in
the synthesis of macrocyclic musk[15] and insect pheromone natural products.[16]
The Z-selectivity exhibited by all known Z-selective catalysts is believed to be because of
steric crowding around the transition metal center. Large ligands held over a single face of
the metal center force the intermediate metallacyclobutane to be formed exclusively in an
all-cis orientation (8), in turn producing olefin products highly enriched in the Z isomer (7,
Scheme 1).[13c] In this way, catalysts 3–6 produce olefin products with kinetic selectivity for
the higher-energy cis olefins. In the case of ruthenium catalysts 5 and 6, this is accomplished
by chelation of the NHC ligand, which positions the N-aryl group over the
metallacyclobutane.[17]
The kinetic selectivity inherent in Z-selective olefin metathesis catalysts provides a platform
for enhanced olefin metathesis chemoselectivity. The preference for the formation of Z
olefins indicates that the reverse reaction should also be highly preferred for Z
olefins. [11c,15,18] As a result, otherwise unbiased E olefins (10) should be significantly less
reactive to metathesis as the intermediate metallacycle 11 is destabilized (Scheme 1). In
2012, the Schrock and Hoveyda groups made use of this principle with MAP catalysts of
molybdenum (3) and tungsten (4) that selectively dimerized terminal E-1,3-dienes to E, Z,
E-trienes with high Z-selectivity and good chemoselectivity for terminal olefins over
internal E olefins.[19] Herein, we report the general use of chelated ruthenium catalysts (5
and 6) to perform chemoselective cross metathesis.[16,20] Catalyst 6 was discovered to
provide products of cross metathesis with essentially complete chemo- and stereoselectivity
with a wide substrate scope.
Initial catalyst investigations were conducted with 8-nonenol (9a) and trans-1,4-hexadiene
(Table 1). Reactions were conducted in open vessels to facilitate efficient ethylene
removal.[21] Ruthenium complex 5 provided cross product 12a in good yield and Z-
selectivity (entry 1). Catalyst 6, bearing the bulkier 2,6-diisopropylphenyl group, has
recently been shown to exhibit superior reactivity and Z-selectivity.[14d] Indeed, complex 6
provided diene 12a in similar yields with essentially complete stereoselectivity (entry 2).
Production of diene 12a was observed with catalyst loadings as low as 0.1 mol %, though
the conversion was diminished (entries 3 and 4). Unchelated dichloride catalyst 1 provided
no observable amount of the desired cross product (entry 5), producing primarily oligomeric
products of unselective cross metathesis of 1,4-hexadiene. Less reactive catalyst 2, provided
some 12a, however the yield and stereoselectivity were low (entry 6). For future
investigations, we chose 1 mol % of catalyst 6 in a 0.5 M solution of substrate in 1:1
THF:hexadiene as optimal conditions to achieve sufficient reaction rate with most
substrates.
The scope was further investigated with trans-1,4-hexadiene as the metathesis partner (Table
2). A number of functionalized terminal olefins were reacted in modest to good yields.
Carbonyl functionality such as aldehydes (entry 2), ketones (entry 3), and esters (entry 4)
were well tolerated. Allylic amine functionality did not significantly compromise the
conversion or overall yields (entries 5–6). Synthetically useful Z-allylic carbonates (12h)
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and boronic esters (12i) could also be produced in modest yields (entries 7–8). In all cases
no products derived from cross metathesis of the internal E-olefin were observed, providing
complete chemoselectivity for the cross metathesis of terminal olefins in the presence of
unbiased E-olefins. Comparable yields were also obtained on reactions conducted on 1
mmol scale, indicating the robustness of this methodology (Table 1, entry 2 and Table 2,
entries 2 and 6).
The diene partner could also be used as the limiting reagent (Table 3). The terminal olefin of
diene 13a reacted preferentially over the E-α,β-unsaturated ester in good yield (entry 1).
Cross metathesis of diene 13b with 1-decene occurred in similarly good yield and Z-
selectivity (entry 1). The proximity of a functionalized trans olefin effects the efficiency of
the reaction. Diene 13c required higher catalyst loading to provide a modest yield of E, Z-
diene 12l (entry 3). Interestingly, trans-2,5-hexadiene-1-ol (13d) was unreactive towards
cross metathesis (entries 4). This lack of reactivity is due to the oxygen functionality rather
than protic substrates, as related benzoate ester 13e was also unreactive (entry 5).
Furthermore, 1,3-dienes, used as the limiting reagent or in excess, were similarly unreactive
to metathesis (e.g. 13f, entry 6).
Chelated ruthenium catalyst 6 is sensitive to the steric environment of the reacting olefin. As
a result, monosubstituted terminal olefins are also preferentially reacted over disubstituted
alkenes (eq 1). When diene 14 was reacted with 8-nonenol (9a), as either the limiting
reagent or in excess, metathesis only occured at the less substituted olefin to produce diene
15 as the major product.[22]
(1)
Chemoselectivity can also be driven by electronic factors. α,β-Unsaturated ester 13g was
preferentially metathesized at the terminal olefin to provide Z, Z-diene 12p in good yield
and selectivity (eq 2). The electron-withdrawing nature of the methyl ester was sufficient to
deactivate the internal Z olefin towards metathesis with catalyst 6. As a result, both E- and
Z-α,β-unsaturated esters are unreactive to metathesis with catalyst 2.
(2)
Chemoselective cross metathesis can also be performed from internal Z-olefins. Cis-6-
nonen-1-ol (16) underwent cross metathesis with trans-1,4-hexadiene to provide diene 12q
as the major cross metathesis product (eq 3). Cross metathesis in this case likely occurred by
initial ethenolysis of 16 to 6-hepten-1-ol by a ruthenium methylidene generated by
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dimerization of trans-1,4-hexadiene.[16] The terminal alkene was then able to undergo
further metathesis to afford E, Z-diene 12q.
(3)
Chemoselective macrocyclic ring-closing metathesis was also possible with catalyst 5 (eq
4). Utilizing conditions previously optimized for Z-selective macrocyclic ring-closing
metathesis of dienes (7.5 mol % catalyst loading under static vacuum of 100 mTorr),[15] the
terminal alkenes of triene 17 were selectively reacted to provide 17-membered lactone 18,
which contains both internal E and Z double bonds. For this transformation, less hindered
catalyst 5 was necessary for sufficient conversion.[23] High Z selectivity was observed for
the newly formed olefin, and no products of metathesis of the E olefin were observed. It is
important to note that this ring-closing metathesis would be extremely challenging using
previous generations of metathesis catalysts (e.g. 1 or 2). Furthermore, the mass balance of
this transformation was primarily recovered triene 17, with small amounts of oligomeric
material.
(4)
In summary, chemoselective cross metathesis has been demonstrated with Z-selective
ruthenium metathesis catalysts. Catalyst 2 preferentially reacts with terminal and internal Z-
olefins to prepare E, Z-dienes in good yields with complete stereoselectivity. Additionally,
this preference was extended to sterically and electronically deactivated olefins.
Chemoselective macrocyclic ring-closing metathesis was also achieved. Ruthenium complex
6 exhibits broad substrate compatibility and scope. While there are some limitations in
compatible dienes, as new catalysts are discovered, the utility and scope of these
chemoselective transformations will improve. The chemoselectivity of ruthenium catalysts 5
and 6 provide new avenues for the synthesis of polyenes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Prominent Olefin Metathesis Catalysts (Ar = 2,6-(2,4,6-iPr3C6H2)2C6H3; SIMes = 1,3-
Bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene)
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Scheme 1.
Destabilized trans metallacyclobutane 11 disfavors metathesis of E-olefins
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Table 2
Scope of Cross Metathesis with trans-1,4-Hexadiene[a]
entry R 12 yield[b] (%) Z (%)[c]
1 CH2Ph 12b 63[d] >95
2 (CH2)8CHO 12c 70 (65)[e] >95
3 (CH2)2COCH3 12d 49 >95
4 (CH2)7CO2Me 12e 82 >95
5 CH2NHPh 12f 68 >95
6 CH2NHBoc 12g 54 (64)[e] >95
7 CH2OCO2Me 12h 79 >95
8 CH2BPin 12i 65 >95
[a]
Reaction conditions: 9 (0.2 mmol), 0.2 mL trans-1,4-hexadiene, 0.2 mL THF, 0.002 mmol 6.
[b]
Isolated yield.
[c]
Determined by 1H NMR analysis.
[d]
Yield determined by 1H NMR analysis with 1,3,5-trimethoxybenzene as an external standard.
[e]
Reaction conditions: 9 (1 mmol), 1 mL trans-1,4-hexadiene, 1 mL THF, 0.01 mmol 6.
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